The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression.

Search: WFRF:(Runeson B) > The mission is remi...

LIBRIS-ID:oai:gup.ub.gu.se/99128
https://gup.ub.gu.se/publication/99128URI
https://doi.org/10.1111/j.1742-1241.2006.00997.xDOI
http://kipublications.ki.se/Default.aspx?queryparsed=id:112220954URI
https://research.hhs.se/esploro/outputs/journalArticle/The-mission-is-remission-health-economic/991001501898506056URI

The aim of the present study was to determine the magnitude of the impact of treating depression to full remission on cost and health-related quality of life. In a naturalistic longitudinal survey recordings of resource use and quality of life were carried out among depressed patients treated with antidepressant therapy in 56 Swedish primary care clinics. We found that a total of 52% of the patients achieved full remission during the study period. Remitting patients had, on average, three outpatient visits less than non-remitting patients (p < 0.01), 22 fewer sick leave days (p = 0.01), which translated into a significantly lower total cost (Euro 2700) compared with non-remitting patients (p < 0.01). Health-related quality-of-life scores improved by 40% for remitting patients when compared with non-remitting ones (p < 0.01). We conclude that remission has a substantial health economic impact on patients treated for depression, which further strengthens the importance of aiming for full remission in the treatment of depression.

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Psykiatri hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Psychiatry hsv//eng
MEDICIN OCH HÄLSOVETENSKAP Hälsovetenskap Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi hsv//swe
MEDICAL AND HEALTH SCIENCES Health Sciences Health Care Service and Management, Health Policy and Services and Health Economy hsv//eng
Adult
Ambulatory Care
economics
statistics & numerical data
Antidepressive Agents
economics
therapeutic use
Cost of Illness
Cost-Benefit Analysis
Depressive Disorder
drug therapy
economics
Female
Humans
Longitudinal Studies
Male
Quality of Life
Remission Induction
Sick Leave
economics
statistics & numerical data
Time Factors
Treatment Outcome

Ekman, MStockholm Health Economics (author)
Ågren, Hans,1945Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,Karolinska University Hospital(Swepub:gu)xagrha (author)
Runeson, BKarolinska Institutet (author)
Jönsson, B.Stockholm School of Economics,Handelshögskolan i Stockholm(Swepub:hhs)211@hhs.se (author)
Karolinska InstitutetStockholm Health Economics (creator_code:org_t)

In:International journal of clinical practice: Hindawi Limited60:7, s. 791-81368-50311742-1241

By the author/editor: Sobocki, P; Ekman, M; Ågren, Hans, 194 ...; Runeson, B; Jönsson, B.

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Psychiatry

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Health Sciences; and Health Care Serv ...

By the university: University of Gothenburg; Karolinska Institutet; Stockholm School of Economics

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.